Jason Springs is currently the CEO of GeneWeave Biosciences, LLC. His company develops diagnostic devices that detect the presence and drug-resistance of disease-causing bacteria without the need for a diagnostic laboratory. The company is particularly focused on detecting so-called "superbugs" -disease-causing bacteria that are resistant or immune to standard antibiotics, as well as bacteria responsible for many hospital-acquired infections (HAIs).
Jason Springs is a first year MBA student at the Johnson School at Cornell University. He received his undergraduate degree in Economics and Management from the University of South Carolina.
The competitive landscape, who are we looking at. You got really three technologies including ours that we would look at. We use engineered viruses, very low cost, incredibly accurate. On the easier side, you got just standard culturing just like a student would do in a high school biology class ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
Jason Springs Discusses Challenges of Dealing With FDA and Ensuring That Supply Chain Has Enough Volume
Jason Springs States He Chose Cornell For Graduate Work Because of Collaborative Opportunities
Jason Springs Discusses Impact Of Running A Business While Taking Courses As An MBA Student
Jason Springs States Being An Entrepreneur Is All About Creating Something New and Transformative
Jason Springs Discusses Differences In Pursuing Entrepreneurial Career Path Versus Traditional Path
Jason Springs States If You Aren't Making Mistakes Then You Aren't Trying Hard Enough
